Massachusetts General Laws
Chapter 6d - Health Policy Commission
Section 19 - Early Childhood Investment Opportunity Grant Program

[Text of section effective until July 1, 2021. Repealed by 2018, 208, Sec. 108. See 2018, 208, Sec. 109.]
Section 19. Subject to appropriation, the health policy commission, in consultation with the department of public health, shall create and administer an early childhood investment opportunity grant program for programs to support and care for families with substance exposed newborns, including the study of long-term effects of neonatal abstinence syndrome on children up to the age of 18. The program shall support a model that includes both medical services and traditionally non-reimbursed services and may support services provided in clinic settings or in-home visits. The commission shall report to the joint committee on mental health, substance use and recovery and the house and senate committees on ways and means not later than 12 months following completion of the grant program on the results of the programs and the findings of the study on the long-term effects of neonatal abstinence syndrome, including their effectiveness, efficiency, and sustainability.
[Chapter 6E added by 2020, 253, Sec. 30 effective July 1, 2021. See 2020, 253, Sec. 122.]

Structure Massachusetts General Laws

Massachusetts General Laws

Part I - Administration of the Government

Title II - Executive and Administrative Officers of the Commonwealth

Chapter 6d - Health Policy Commission

Section 1 - Definitions

Section 2 - Health Policy Commission; Governing Board; Members; Duties and Powers; Annual Report

Section 2a - Confidentiality of Nonpublic Clinical, Financial, Strategic or Operational Documents

Section 3 - Board Powers and Duties

Section 4 - Advisory Council

Section 5 - Monitoring of Health Care Delivery and Payment System

Section 6 - Payment by Acute Hospital, Ambulatory Surgical Center or Surcharge Payor for Estimated Expenses of Commission

Section 7 - Administration of the Healthcare Payment Reform Fund; Competitive Process for Development of Health Care Payment and Service Delivery Models; Annual Report

Section 8 - Public Hearings; Witnesses; Annual Report

Section 8a - Pharmaceutical Drug Pricing; Manufacturer Disclosure of Pricing Information; Determination of Supplemental Rebate, Proposed Value or Reasonableness of Pricing of a Drug

Section 9 - Health Care Cost Growth Benchmark; Modification

Section 10 - Notice to Health Care Entities Exceeding Health Care Cost Growth Benchmark; Performance Improvement Plan; Waiver; Penalty for Failure to Comply

Section 11 - Registration Program for Provider Organizations; Division of Insurance Risk Certificate

Section 12 - Negotiation of Network Contracts by Unregistered Provider or Provider Organization Prohibited

Section 13 - Notice of Material Changes to Operations or Governance Structure of Provider or Provider Organization; Cost and Market Impact Review

Section 14 - Standards of Certification for Patient-Centered Medical Homes; Coordination of Care; Quality Standards

Section 15 - Certification as Accountable Care Organization (Aco); Standards

Section 16 - Office of Patient Protection; Powers and Duties; External Review System

Section 17 - Annual Report; Audits

Section 18 - Adoption of Regulations to Implement Chapter 6d

Section 19 - Early Childhood Investment Opportunity Grant Program